211 related articles for article (PubMed ID: 30372367)
1. Safety of ambroxol in the treatment of airway diseases in adult patients.
Cazan D; Klimek L; Sperl A; Plomer M; Kölsch S
Expert Opin Drug Saf; 2018 Dec; 17(12):1211-1224. PubMed ID: 30372367
[TBL] [Abstract][Full Text] [Related]
2. Safety and usage pattern of an over-the-counter ambroxol cough syrup: a community pharmacy-based cohort study.
Schulz M; Hämmerlein A; Hinkel U; Weis G; Gillissen A
Int J Clin Pharmacol Ther; 2006 Sep; 44(9):409-21. PubMed ID: 16995329
[TBL] [Abstract][Full Text] [Related]
3. Ambroxol in the 21st century: pharmacological and clinical update.
Malerba M; Ragnoli B
Expert Opin Drug Metab Toxicol; 2008 Aug; 4(8):1119-29. PubMed ID: 18680446
[TBL] [Abstract][Full Text] [Related]
4. Characterization of differential patient profiles and therapeutic responses of pharmacy customers for four ambroxol formulations.
Kardos P; Beeh KM; Sent U; Mueck T; Gräter H; Michel MC
BMC Pharmacol Toxicol; 2018 Jul; 19(1):40. PubMed ID: 29973292
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of ambroxol lozenges in the treatment of acute uncomplicated sore throat. EBM-based clinical documentation.
de Mey C; Peil H; Kölsch S; Bubeck J; Vix JM
Arzneimittelforschung; 2008; 58(11):557-68. PubMed ID: 19137906
[TBL] [Abstract][Full Text] [Related]
6. An overview of efficacy and safety of ambroxol for the treatment of acute and chronic respiratory diseases with a special regard to children.
Kantar A; Klimek L; Cazan D; Sperl A; Sent U; Mesquita M
Multidiscip Respir Med; 2020 Jan; 15(1):511. PubMed ID: 32269775
[No Abstract] [Full Text] [Related]
7. [More than expectorant: new scientific data on ambroxol in the context of the treatment of bronchopulmonary diseases].
Plomer M; de Zeeuw J
MMW Fortschr Med; 2017 Jun; 159(Suppl 5):22-33. PubMed ID: 28643291
[TBL] [Abstract][Full Text] [Related]
8. Mucoactive agents for adults with acute lung conditions: A systematic review.
Tarrant BJ; Maitre CL; Romero L; Steward R; Button BM; Thompson BR; Holland AE
Heart Lung; 2019; 48(2):141-147. PubMed ID: 30409442
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and safety of salbutamol/ambroxol fixed-dose combination granules in healthy Chinese subjects
.
Wang Y; Lu J; Li T; Zhao S; Yang W; Liu L; Shi X; Michael M; Ding L
Int J Clin Pharmacol Ther; 2018 Dec; 56(12):597-603. PubMed ID: 30232958
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of the efficacy and safety of a combination drug containing ambroxol, guaifenesin, and levosalbutamol versus a fixed-dose combination of bromhexine/guaifenesin/salbutamol in the treatment of productive cough in adult patients with acute bronchitis].
Zaitsev AA; Leshchenko IV; Esaulova NA; Viktorova IA
Ter Arkh; 2023 Apr; 95(3):236-242. PubMed ID: 37167145
[TBL] [Abstract][Full Text] [Related]
11. Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis.
Nash EF; Stephenson A; Ratjen F; Tullis E
Cochrane Database Syst Rev; 2009 Jan; (1):CD007168. PubMed ID: 19160327
[TBL] [Abstract][Full Text] [Related]
12. [Mucolytics in acute and chronic respiratory tract disorders. I. Pathophysiology and mechanisms of action].
Kupczyk M; Kuna P
Pol Merkur Lekarski; 2002 Mar; 12(69):245-7. PubMed ID: 12053600
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Ambroxol Lozenges in the Treatment of Acute Uncomplicated Sore Throat - a Pooled Analysis.
de Mey C; Koelsch S; Richter E; Pohlmann T; Sousa R
Drug Res (Stuttg); 2016 Jul; 66(7):384-92. PubMed ID: 27281448
[TBL] [Abstract][Full Text] [Related]
14. [Antioxidative features of ambroxol--usefulness in COPD].
Nowak D
Pneumonol Alergol Pol; 2001; 69(9-10):590-3. PubMed ID: 11928667
[No Abstract] [Full Text] [Related]
15. [Efficacy and safety of acute bronchitis treatment in adults--a comparison of Bronchosol® syrup and synthetic preparations with ambroxol. Results of observational study].
Fal AM; Schönknecht K
Wiad Lek; 2015; 68(2):139-44. PubMed ID: 26181148
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of ambroxol hydrochloride lozenges in sore throat. Randomised, double-blind, placebo-controlled trials regarding the local anaesthetic properties.
Fischer J; Pschorn U; Vix JM; Peil H; Aicher B; Müller A; de Mey C
Arzneimittelforschung; 2002; 52(4):256-63. PubMed ID: 12040968
[TBL] [Abstract][Full Text] [Related]
17. [Mucolytics in acute and chronic respiratory tract disorders. II. Uses for treatment and antioxidant properties].
Kupczyk M; Kuna P
Pol Merkur Lekarski; 2002 Mar; 12(69):248-52. PubMed ID: 12053601
[TBL] [Abstract][Full Text] [Related]
18. Ambroxol inhalation ameliorates LPS-induced airway inflammation and mucus secretion through the extracellular signal-regulated kinase 1/2 signaling pathway.
Zhang SJ; Jiang JX; Ren QQ; Jia YL; Shen J; Shen HJ; Lin XX; Lu H; Xie QM
Eur J Pharmacol; 2016 Mar; 775():138-48. PubMed ID: 26872986
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of high doses of ambroxol treatment for acute lung injury/acute respiratory distress syndrome based on randomized controlled trials.
Wu X; Li S; Zhang J; Zhang Y; Han L; Deng Q; Wan X
J Clin Pharmacol; 2014 Nov; 54(11):1199-206. PubMed ID: 25174313
[TBL] [Abstract][Full Text] [Related]
20. Unexpected infant deaths associated with use of cough and cold medications.
Chang CY; Sachs HC; Lee CE
Pediatrics; 2009 Feb; 123(2):e358-9;author reply e359. PubMed ID: 19171592
[No Abstract] [Full Text] [Related]
[Next] [New Search]